ZEB1 and neoplasm: While the exact histone residue responsible for this regulation in neuroendocrine prostate cancer has not been unequivocally mapped, current evidence supports a model in which lactylation at H3K18 or H3K9 promotes ZEB1 expression and facilitates lineage plasticity during tumor progression.